Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on sleep in brain health

LIVE: Thursday 2nd May 2024, 18:00-19:30 (CEST)

Quality sleep is essential for health. But what happens to our brains when sleep patterns are disturbed? Join our experts to explore the interplay between sleep disruption and neurological diseases, and the questions that you need to be asking your patients to help you prevent the harmful effects of sleep deprivation.
ADVANCED SEARCH
Log in
Top
BMC Musculoskeletal Disorders
Published in: BMC Musculoskeletal Disorders 1/2013

Open Access 01-12-2013 | Research article

Safety reporting on implantation of autologous adipose tissue-derived stem cells with platelet-rich plasma into human articular joints

Authors: Jaewoo Pak, Jae-Jin Chang, Jung Hun Lee, Sang Hee Lee

Published in: BMC Musculoskeletal Disorders | Issue 1/2013

Login to get access

Abstract

Background

Adipose tissue-derived stem cells (ADSCs), a type of mesenchymal stem cells (MSCs), have great potential as therapeutic agents in regenerative medicine. Numerous animal studies have documented the multipotency of ADSCs, showing their capabilities to differentiate into tissues such as muscle, bone, cartilage, and tendon. However, the safety of autologous ADSC injections into human joints is only beginning to be understood and the data are lacking.

Methods

Between 2009 and 2010, 91 patients were treated with autologous ADSCs with platelet-rich plasma (PRP) for various orthopedic conditions. Stem cells in the form of stromal vascular fraction (SVF) were injected with PRP into various joints (n = 100). All patients were followed for symptom improvement with visual analog score (VAS) at one month and three months. Approximately one third of the patients were followed up with third month magnetic resonance imaging (MRI) of the injected sites. All patients were followed up by telephone questionnaires every six months for up to 30 months.

Results

The mean follow-up time for all patients was 26.62 ± 0.32 months. The follow-up time for patients who were treated in 2009 and early 2010 was close to three years. The relative mean VAS of patients at the end of one month follow-up was 6.55 ± 0.32, and at the end of three months follow-up was 4.43 ± 0.41. Post-procedure MRIs performed on one third of the patients at three months failed to demonstrate any tumor formation at the implant sites. Further, no tumor formation was reported in telephone long-term follow-ups. However, swelling of injected joints was common and was thought to be associated with death of stem cells. Also, tenosinovitis and tendonitis in elderly patients, all of which were either self-limited or were remedied with simple therapeutic measures, were common as well.

Conclusions

Using both MRI tracking and telephone follow ups in 100 joints in 91 patients treated, no neoplastic complications were detected at any ADSC implantation sites. Based on our longitudinal cohort, the autologous and uncultured ADSCs/PRP therapy in the form of SVF could be considered to be safe when used as percutaneous local injections.
Appendix
Available only for authorised users
Literature
1.
Ando W, Tateishi K, Hart DA, Katakai D, Tanaka Y, Nakata K, Hashimoto J, Fujie H, Shino K, Yoshikawa H, Nakamura N: Cartilage repair using an in vitro generated scaffold-free tissue-engineered construct derived from porcine synovial mesenchymal stem cells. Biomaterials. 2007, 28: 5462-5470. 10.1016/j.biomaterials.2007.08.030.CrossRefPubMed
2.
Ando W, Tateishi K, Katakai D, Hart DA, Hiquchi C, Nakata K, Hashimoto J, Fujie H, Shino K, Yoshikawa H, Nakamura N: In vitro generation of a scaffold-free tissue-engineered construct (TEC) derived from human synovial mesenchymal stem cells: biological and mechanical properties, and further chondrogenic potential. Tissue Eng Part A. 2008, 14: 2041-2049. 10.1089/ten.tea.2008.0015.CrossRefPubMed
3.
Tallheden T, Dennis JE, Lennon DP, Sjoqren-Jansson E, Caplan AI, Lindahl A: Phenotypic plasticity of human articular chondrocytes. J Bone Joint Surg Am. 2003, 85-A (Suppl): 93-100.PubMed
4.
Nevo Z, Robinson D, Horowitz S, Hasharoni A, Yayon A: The manipulated mesenchymal stem cells in regenerated skeletal tissues. Cell Transplant. 1998, 7: 63-70. 10.1016/S0963-6897(97)00066-3.CrossRefPubMed
5.
Bielby R, Jones E, McGonagle D: The role of mesenchymal stem cells in maintenance and repair of bone. Injury. 2007, 38 (Suppl): 26-32.CrossRef
6.
Wakitani S, Goto T, Pineda SJ, Young RG, Mansour JM, Caplan AI, Goldberg VM: Mesenchymal cell-based repair of large, full-thickness defects of articular cartilage. J Bone Joint Surg Am. 1994, 76: 579-592.PubMed
7.
Sakai D, Mochida J, Yamamoto Y, Nomura T, Okuma M, Nishimura K, Nakai T, Ando K, Hotta T: Transplantation of mesenchymal stem cells embedded in Atelocollagen gel to the intervertebral disc: a potential therapeutic model for disc degeneration. Biomaterials. 2003, 24: 3531-3541. 10.1016/S0142-9612(03)00222-9.CrossRefPubMed
8.
Johnstone B, Yoo JU: Autologous mesenchymal progenitor cells in articular cartilage repair. Clin Orthop Relat Res. 1999, 367 (Suppl): 156-162.CrossRef
9.
Agung M, Ochi M, Yanada S, Adachi N, Izuta Y, Yamasaki T, Toda K: Mobilization of bone marrow derived mesenchymal stem cells into the injured tissues after intraarticular injection and their contribution to tissue regeneration. Knee Surg Sports Traumatol Arthrosc. 2006, 14: 1307-1314. 10.1007/s00167-006-0124-8.CrossRefPubMed
10.
Sakai D, Mochida J, Iwashina T, Watanabe T, Nakai T, Ando K, Hotta T: Differentiation of mesenchymal stem cells transplanted to a rabbit degenerative disc model: potential and limitations for stem cell therapy in disc regeneration. Spine. 2005, 30: 2379-2387. 10.1097/01.brs.0000184365.28481.e3.CrossRefPubMed
11.
Walsh CJ, Goodman D, Caplan AI, Goldberg VM: Meniscus regeneration in a rabbit partial meniscectomy model. Tissue Eng. 1999, 5: 327-337. 10.1089/ten.1999.5.327.CrossRefPubMed
12.
Nishimori M, Deie M, Kanaya A, Exham H, Adachi N, Ochi M: Repair of chronic osteochondral defects in the rat. A bone marrow-stimulating procedure enhanced by cultured allogenic bone marrow mesenchymal stromal cells. J Bone Joint Surg Br. 2006, 88: 1236-1244.CrossRefPubMed
13.
Yamasaki T, Deie M, Shinomiya R, Izuta Y, Yasunaqa Y, Yanada S, Sharman P, Ochi M: Meniscal regeneration using tissue engineering with a scaffold derived from a rat meniscus and mesenchymal stromal cells derived from rat bone marrow. J Biomed Mater Res A. 2005, 75: 23-30.CrossRefPubMed
14.
Kanaya A, Deie M, Adachi N, Nishimori M, Yanada S, Ochi M: Intra-articular injection of mesenchymal stromal cells in partially torn anterior cruciate ligaments in a rat model. Arthroscopy. 2007, 23: 610-617. 10.1016/j.arthro.2007.01.013.CrossRefPubMed
15.
16.
Centeno CJ, Kisiday J, Freeman M, Schultz JR: Partial regeneration of the human hip via autologous bone marrow nucleated cell transfer: a case study. Pain Physician. 2006, 9: 253-256.PubMed
17.
Centeno CJ, Busse D, Kisiday J, Keohan C, Freeman M, Karli D: Regeneration of meniscus cartilage in a knee treated with percutaneously implanted autologous mesenchymal stem cells. Med Hypotheses. 2008, 71: 900-908. 10.1016/j.mehy.2008.06.042.CrossRefPubMed
18.
Giannini S, Buda R, Cavallo M, Ruffilli A, Cenacchi A, Cavallo C, Vannini F: Cartilage repair evolution in post-traumatic osteochondral lesions of the talus: from open field autologous chondrocyte to bone-marrow-derived cells transplantation. Injury. 2010, 41: 1196-1203. 10.1016/j.injury.2010.09.028.CrossRefPubMed
19.
Pak J: Autologous adipose tissue-derived stem cells induce persistent bone-like tissue in osteonecrotic femoral heads. Pain Physician. 2012, 15: 75-85.PubMed
20.
21.
Kulakov AA, Goldshtein DV, Grigoryan AS, Rzhaninova AA, Alekseeva IS, Arutyunyan IV, Volkov AV: Clinical study of the efficiency of combined cell transplant on the basis of multipotent mesenchymal stromal adipose tissue cells in patients with pronounced deficit of the maxillary and mandibulary bone tissue. Bull Exp Biol Med. 2008, 146: 522-525. 10.1007/s10517-009-0322-8.CrossRefPubMed
22.
Mesimäki K, Lindroos B, Törnwall J, Mauno J, Lindqvist C, Kontio R, Miettinen S, Suuronen R: Novel maxillary reconstruction with ectopic bone formationby GMP adipose stem cells. Int J Oral Maxillofac Surg. 2009, 38: 201-209. 10.1016/j.ijom.2009.01.001.CrossRefPubMed
23.
Taylor JA: Bilateral orbitozygomatic reconstruction with tissue-engineered bone. J Craniofac Surg. 2010, 21: 1612-1614. 10.1097/SCS.0b013e3181edc829.CrossRefPubMed
24.
Kuroda R, Ishida K, Matsumoto T, Akisue T, Fujioka H, Mizuno K, Ohgushi H, Wakitani S, Kurosaka M: Treatment of a full-thickness articular cartilage defect in the femoral condyle of an athlete with autologous bone marrow-stromal cells. Osteoarthr Cartil. 2007, 15: 226-231. 10.1016/j.joca.2006.08.008.CrossRefPubMed
25.
Slynarski K, Deszczynski J, Karpinski J: Fresh bone marrow and periosteum transplantation for cartilage defects of the knee. Transplant Proc. 2006, 38: 318-319. 10.1016/j.transproceed.2005.12.075.CrossRefPubMed
26.
Wakitani S, Okabe T, Horibe S, Mitsuoka T, Saito M, Koyama T, Nawata M, Tensho K, Kato H, Uematsu K, Kuroda R, Kurosaka M, Yoshiya S, Hattori K, Ohgushi H: Safety of autologous bone marrow-derived mesenchymal stem cell transplantation for cartilage repair in 41 patients with 45 joints followed for up to 11 years and 5 months. J Tissue Eng Regen Med. 2011, 5: 146-150. 10.1002/term.299.CrossRefPubMed
27.
28.
Zuk PA, Zhu M, Ashjian P, De Ugarte DA, Huang JI, Mizuno H, Alfonso ZC, Fraser JK, Benhaim P, Hedrick MH: Human adipose tissue is a source of multipotent stem cells. Mol Biol Cell. 2002, 13: 4279-4295. 10.1091/mbc.E02-02-0105.CrossRefPubMedPubMedCentral
29.
Martineau I, Lacoste E, Gagnon G: Effects of calcium and thrombin on growth factor release from platelet concentrates: kinetics and regulation of endothelial cell proliferation. Biomaterials. 2004, 25: 4489-4502. 10.1016/j.biomaterials.2003.11.013.CrossRefPubMed
30.
Doucet C, Ernou I, Zhang Y, Llense JR, Begot L, Holy X, Lataillade JJ: Platelet lysates promote mesenchymal stem cell expansion: a safety substitute for animal serum in cell-based therapy applications. J Cell Physiol. 2005, 205: 228-236. 10.1002/jcp.20391.CrossRefPubMed
31.
Bernardo ME, Avanzini MA, Perotti C, Cometa AM, Moretta A, Lenta E, Del Fante C, Novara F, de Silvestri A, Amendola G, Zuffardi O, Maccario R, Locatelli F: Optimization of in vitro expansion of human multipotent mesenchymal stromal cells for cell-therapy approaches: further insights in the search for a fetal calf serum substitute. J Cell Physiol. 2007, 211: 121-130. 10.1002/jcp.20911.CrossRefPubMed
32.
Müller I, Kordowich S, Holzwarth C, Spa-no C, Isensee G, Staiber A, Viebahn S, Gieseke F, Langer H, Gawaz MP, Horwitz EM, Conte P, Handgretinger R, Dominici M: Animal serum-free culture conditions for isolation and expansion of multipotent mesenchymal stromal cells from human BM. Cytotherapy. 2006, 8: 437-444. 10.1080/14653240600920782.CrossRefPubMed
33.
Schallmoser K, Bartmann C, Rohde E, Reinisch A, Kashofer K, Stadelmeyer E, Drexler C, Lanzer G, Linkesch W, Strunk D: Human platelet lysate can replace fetal bovine serum for clinical-scale expansion of functional mesenchymal stromal cells. Transfusion. 2007, 47: 1436-1446. 10.1111/j.1537-2995.2007.01220.x.CrossRefPubMed
34.
Centeno CJ, Schultz JR, Cheever M, Robinson B, Freeman M, Marasco W: Safety and complications reporting on the re-implantation of culture-expanded mesenchymal stem cells using autologous platelet lysate technique. Curr Stem Cell Res Ther. 2010, 5: 81-93. 10.2174/157488810790442796.CrossRefPubMed
35.
Miura M, Miura Y, Padilla-Nash HM, Molinolo AA, Fu B, Patel V, Seo BM, Sonoyama W, Zheng JJ, Baker CC, Chen W, Ried T, Shi S: Accumulated chromosomal instability in murine bone marrow mesenchymal stem cells leads to malignant transformation. Stem Cells. 2006, 24: 1095-1103. 10.1634/stemcells.2005-0403.CrossRefPubMed
36.
Bochkov NP, Voronina ES, Kosyakova NV, Liehr T, Rzhaninova AA, Katosova LD, Platonova VI, Gol’dshtein DV: Chromosome variability of human multipotent mesenchymal stromal cells. Bull Exp Biol Med. 2007, 143: 122-126. 10.1007/s10517-007-0031-0.CrossRefPubMed
37.
Izadpanah R, Kaushal D, Kriedt C, Tsien F, Patel B, Dufour J, Bunnell BA: Long-term in vitro expansion alters the biology of adult mesenchymal stem cells. Cancer Res. 2008, 68: 4229-4238. 10.1158/0008-5472.CAN-07-5272.CrossRefPubMedPubMedCentral
38.
Bernardo ME, Zaffaroni N, Novara F, Cometa AM, Avanzini MA, Moretta A, Montaqna D, Maccario R, Villa R, Daidone MG, Zuffardi O, Locatelli F: Human bone marrow derived mesenchymal stem cells do not undergo transformation after long-term in vitro culture and do not exhibit telomere maintenance mechanisms. Cancer Res. 2007, 67: 9142-9149. 10.1158/0008-5472.CAN-06-4690.CrossRefPubMed
39.
Vacanti V, Kong E, Suzuki G, Sato K, Canty JM, Lee T: Phenotypic changes of adult porcine mesenchymal stem cells induced by prolonged passaging in culture. J Cell Physiol. 2005, 205: 194-201. 10.1002/jcp.20376.CrossRefPubMed
40.
Amrani DL, Port S: Cardiovascular disease: potential impact of stem cell therapy. Expert Rev Cardiovasc Ther. 2003, 1: 453-461. 10.1586/14779072.1.3.453.CrossRefPubMed
41.
Korean Food and Drug Administration: Cell therapy: Rules and Regulations, Chapter 2, Section 14. 2009, Seoul (Korea): The Organization
42.
Fan W, Cheng K, Qin X, Narsinh KH, Wang S, Hu S, Wang Y, Chen Y, Wu JC, Xiong L, Cao F: mTORC1 and mTORC2 play different roles in the functional survival of transplanted adipose-derived stromal cells in hindlimb ischemic mice via regulating inflammation in vivo. Stem Cells. 2013, 31: 203-214. 10.1002/stem.1265.CrossRefPubMed
43.
44.
Halperin N, Axer A: The painful semimembranosus syndrome. Harefuah. 1978, 94: 329-330.PubMed
45.
Almekinders LC, Vellema JH, PS : Strain patterns in the patellar tendon and the implications for patellar tendinopathy. Knee Surg Sports Traumatol Arthrosc. 2002, 10: 2-5. 10.1007/s001670100224.CrossRefPubMed
46.
Horie M, Sekiya I, Muneta T, Ichinose S, Matsumoto K, Saito H, Murakami T, Kobayashi E: Intra-articular Injected synovial stem cells differentiate into meniscal cells directly and promote meniscal regeneration without mobilization to distant organs in rat massive meniscal defect. Stem Cells. 2009, 27: 878-887. 10.1634/stemcells.2008-0616.CrossRefPubMed
Metadata
Title
Safety reporting on implantation of autologous adipose tissue-derived stem cells with platelet-rich plasma into human articular joints
Authors
Jaewoo Pak
Jae-Jin Chang
Jung Hun Lee
Sang Hee Lee
Publication date
01-12-2013
Publisher
BioMed Central
Published in
BMC Musculoskeletal Disorders / Issue 1/2013
Electronic ISSN: 1471-2474
DOI
https://doi.org/10.1186/1471-2474-14-337

Other articles of this Issue 1/2013

BMC Musculoskeletal Disorders 1/2013 Go to the issue

Research article

Developing a model osteoarthritis consultation: a Delphi consensus exercise

Research article

Patient preferences for adherence to treatment for osteoarthritis: the MEdication Decisions in Osteoarthritis Study (MEDOS)

Study protocol

Evaluation of the effect of a comprehensive multidisciplinary care pathway for hip fractures: design of a controlled study

Case report

Pathologic thoracic spine fracture in presence of Parkinson’s disease and diffuse ankylosis: successful management of a challenging condition

Research article

Effect of interleukin-1β treatment on co-cultures of human meniscus cells and bone marrow mesenchymal stromal cells

Research article

The effect of depressive symptoms on the association between radiographic osteoarthritis and knee pain: a cross-sectional study